Search results for: Health Data and Statistics
Filter search results
OHE Lunchtime Seminar: Economic Evaluation for Decision-Making and the Value of Access to Individual Patient Data
13 February 2017, 12:00am
…health economics and outcome research data. This involves the use of statistical and decision modelling techniques for the analysis of cost effectiveness data. He has 17 years experience in applied…
Biosimilars: Modelling the Evolution of the Market
16 June 2010
…best option for payers and governments is a ‘market support’ policy that includes the infrastructure investment needed for both monitoring outcomes and collecting PSY and other pharmacovigilance data. Collecting high quality data…
Advancing Rare Disease Care: Challenges and Key Issues
28 February 2025
…and pricing and reimbursement—to support a resilient healthcare and innovation ecosystem for rare diseases. Promoting equitable access to medicines for rare diseases is a key component of the World Health…
Advances in Oncology Modelling: Recent Results from POI Research
18 September 2012
OHE and the Pharmaceutical Oncology Initiative (POI) held a workshop to discuss and debate several key issues in oncology modelling. Participating were more than 50 experts from industry, academia and…
Costs and Bariatric Surgery in England
23 September 2010
…for treatment of illnesses related to obesity is substantial, with the Department of Health estimating the costs at £4.3bn per year. In December 2006, the National Institute for Health and Clinical…
Time Trade Off and Valuing Quality of Life
28 April 2010
In an article in Health Economics, Prof Devlin and her co-authors demonstrate the promise of using Lead Time TTO to value health ‘state worse than death’. They demonstrate the potential…
What Drives Variations in Relative Effectiveness Across Countries?
31 May 2016
…framework, drawing on production function theory, to systematically identify and quantify the determinants of relative effectiveness and sources of variation between populations and healthcare systems; and Test this framework using evidence…
Assessing the Life-cycle Value of Second-generation Antipsychotics in Sweden and the UK
17 July 2019
…in Sweden and the UK, 1994-2017, based on data of usage and volume sales. We collected data from the literature on the effectiveness (QALYs per patient per year) and direct…
OHE’s 50th Celebration: Publications on Tuberculosis Show Constancy and Change
23 August 2012
…more than 100 booklets on various diseases and conditions as part of a series on “current health problems”. Topics included public health issues and health systems challenges – and also…